ABC-04 a Phase 1B Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer.

Trial Profile

ABC-04 a Phase 1B Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Selumetinib (Primary) ; Cisplatin; Gemcitabine
  • Indications Biliary cancer; Gallbladder cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 10 May 2016 Status changed from active, no longer recruiting to completed.
    • 26 Sep 2013 Planned end date changed from 1 Aug 2013 to 1 Jan 2015 as reported by ClinicalTrials.gov.
    • 16 Mar 2013 Accrual to date is 108% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top